EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report

M F Gonzalez-Matamala iD, N Patel, D Kahn-Santoro, R Knibb iD, G Roberts iD, P J Turner iD, A Kazie iD, N Atzert iD, J Bartra iD, K Chetty, A Deschildre iD, F A Dumitru und 18 weitere

Pediatric Allergy and Immunology · 2026-10 · 37 (10)

DOI: 10.1111/pai.70507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 14.10.2026. Verfasst von M F Gonzalez-Matamala und 29 weiteren Autor:innen. Beteiligte Einrichtung: Centro del Alergico, Santiago de Chile, Chile. Hauptthemen laut MEDLINE: Epinephrine, Anaphylaxis, Food Hypersensitivity. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Intranasal adrenaline has been approved in multiple countries for anaphylaxis treatment, based primarily on pharmacokinetic/pharmacodynamic comparisons to adrenaline autoinjectors (AAIs).

Aim

To assess patient and caregiver perspectives regarding emerging non‐injectable adrenaline routes.

Methods

Online survey of adults and caregivers of children with food allergy prescribed AAIs, with international dissemination supported by the European Academy of Allergy and Clinical Immunology (February–April 2025).

Results

We analyzed 542 responses from caregivers and 224 from adults with food allergy. Effectiveness of adrenaline nasal spray (ANS) compared to AAI was rated “extremely important” by 78% of caregivers and 71% of adults. 48% of caregivers and 42% of adults were “extremely worried” that ANS may not work as well as AAI, and 50% and 44% (respectively) that it may not work well enough. Compared with AAI, respondents were less worried about ANS being painful or difficult to carry, and about fear/embarrassment around use, but more worried about side effects and knowing how to use it. Most anticipated being more comfortable using ANS than AAI, and over half anticipated earlier use during anaphylaxis. Only 17.2% of caregivers and 23.2% of adults preferred to be prescribed ANS only. There was interest in sublingual adrenaline due to portability and reduced needle‐related burden, but confidence depended on comparable speed/effectiveness and feasibility during reactions.

Conclusions

Non‐injectable adrenaline is attractive to caregivers and adults, and may improve willingness to carry and use adrenaline. However, demand for evidence of effectiveness, safety, and real‐world feasibility is high, highlighting important information needs for shared decision‐making. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpinephrineAnaphylaxisFood HypersensitivityHumansAdultFemaleMaleChildSurveys and QuestionnairesParentsCaregiversAdministration, IntranasalAdolescentMiddle AgedSelf AdministrationChild, PreschoolYoung Adult

Stichwörter der Autor:innen

adrenalineanaphylaxisauto‐injectorepinephrineintranasalpatient perspectivessublingual

Substanzen

Epinephrine

Autor:innen und Institutionen

  • Centro del Alergico, Santiago de Chile, Chile.
  • Allergy Department, Hospital Clínic Barcelona, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK.
  • Department of Paediatric Allergy, Imperial College Healthcare NHS Trust, London, UK.
  • Allergy MSc Alumni, National Heart and Lung Institute, Imperial College London, London, UK.

ORCID-Profile: M F Gonzalez-Matamala, R Knibb, G Roberts, P J Turner, A Kazie, N Atzert, J Bartra, A Deschildre, W Feleszko, J Gerdts, M H Gowland, T T M Le, C Ozdemir, K Papadopoulou, M Podestà, M Ruano-Zaragoza, H O Skjerven, B Stoilov, L D Valderrama, C Venter, C Woehlk, M Vazquez-Ortiz

Zitieren

APA

Gonzalez-Matamala, M. F., Patel, N., Kahn-Santoro, D., Knibb, R., Roberts, G., Turner, P. J., Kazie, A., Atzert, N., Bartra, J., Chetty, K., Deschildre, A., Dumitru, F. A., Feleszko, W., Gerdts, J., Gowland, M. H., Le, T. T. M., Pité, H., Ozdemir, C., Papadopoulou, K., …, & EAACI Taskforce on Food Allergen Ingestion Risk (2026). International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report. Pediatric Allergy and Immunology, 37(10). https://doi.org/10.1111/pai.70507

Vancouver

Gonzalez-Matamala MF, Patel N, Kahn-Santoro D, Knibb R, Roberts G, Turner PJ, et al. International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report. Pediatric Allergy and Immunology. 2026;37(10). doi:10.1111/pai.70507

BibTeX
@article{GonzalezMatamala2026,
  author = {Gonzalez-Matamala, M F and Patel, N and Kahn-Santoro, D and Knibb, R and Roberts, G and Turner, P J and Kazie, A and Atzert, N and Bartra, J and Chetty, K and Deschildre, A and Dumitru, F A and Feleszko, W and Gerdts, J and Gowland, M H and Le, T T M and Pité, H and Ozdemir, C and Papadopoulou, K and Podestà, M and Raviolo, C and Ruano-Zaragoza, M and Skjerven, H O and Stoilov, B and Valderrama, L D and Venter, C and Woehlk, C and Yonamine, G H and Vazquez-Ortiz, M and EAACI Taskforce on Food Allergen Ingestion Risk, EAACI Taskforce on Food Allergen Ingestion Risk},
  title = {International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {10},
  doi = {10.1111/pai.70507}
}
Kostenlos starten →